Qsemble Capital Management LP Acquires Shares of 20,082 Envista Holdings Co. (NYSE:NVST)

Qsemble Capital Management LP acquired a new stake in shares of Envista Holdings Co. (NYSE:NVST) in the 3rd quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm acquired 20,082 shares of the company’s stock, valued at approximately $397,000.

Other institutional investors and hedge funds have also recently modified their holdings of the company. Mirae Asset Global Investments Co. Ltd. bought a new position in shares of Envista during the third quarter valued at $31,000. GAMMA Investing LLC increased its holdings in shares of Envista by 69.8% during the third quarter. GAMMA Investing LLC now owns 1,766 shares of the company’s stock valued at $35,000 after acquiring an additional 726 shares in the last quarter. Huntington National Bank increased its holdings in shares of Envista by 97.8% during the third quarter. Huntington National Bank now owns 1,919 shares of the company’s stock valued at $38,000 after acquiring an additional 949 shares in the last quarter. Blue Trust Inc. increased its holdings in shares of Envista by 69.7% during the third quarter. Blue Trust Inc. now owns 1,957 shares of the company’s stock valued at $39,000 after acquiring an additional 804 shares in the last quarter. Finally, Allspring Global Investments Holdings LLC increased its holdings in shares of Envista by 50.8% during the third quarter. Allspring Global Investments Holdings LLC now owns 2,161 shares of the company’s stock valued at $43,000 after acquiring an additional 728 shares in the last quarter.

Envista Trading Up 1.5 %

Envista stock opened at $22.33 on Thursday. The business has a 50-day simple moving average of $19.67 and a two-hundred day simple moving average of $18.24. The company has a market cap of $3.84 billion, a P/E ratio of -2.87, a P/E/G ratio of 3.09 and a beta of 1.30. Envista Holdings Co. has a 52-week low of $15.15 and a 52-week high of $25.64. The company has a quick ratio of 1.77, a current ratio of 2.08 and a debt-to-equity ratio of 0.42.

Envista (NYSE:NVST) last posted its quarterly earnings data on Wednesday, October 30th. The company reported $0.12 earnings per share for the quarter, beating analysts’ consensus estimates of $0.09 by $0.03. Envista had a positive return on equity of 3.76% and a negative net margin of 53.42%. The firm had revenue of $601.00 million for the quarter, compared to analysts’ expectations of $590.34 million. During the same period in the previous year, the firm earned $0.43 EPS. The business’s quarterly revenue was down 4.8% on a year-over-year basis. Analysts predict that Envista Holdings Co. will post 0.72 EPS for the current year.

Analyst Ratings Changes

NVST has been the subject of several analyst reports. Wells Fargo & Company initiated coverage on Envista in a report on Tuesday, October 8th. They set an “equal weight” rating and a $20.00 price target for the company. Piper Sandler lifted their price objective on Envista from $16.00 to $17.00 and gave the stock a “neutral” rating in a report on Thursday, October 31st. Robert W. Baird lifted their price objective on Envista from $17.00 to $22.00 and gave the stock a “neutral” rating in a report on Thursday, October 31st. Evercore ISI lifted their price objective on Envista from $18.00 to $23.00 and gave the stock an “outperform” rating in a report on Monday, September 23rd. Finally, JPMorgan Chase & Co. downgraded Envista from an “overweight” rating to a “neutral” rating and reduced their price objective for the stock from $23.00 to $16.00 in a report on Thursday, August 8th. One investment analyst has rated the stock with a sell rating, eleven have assigned a hold rating and three have assigned a buy rating to the stock. According to data from MarketBeat.com, the company currently has an average rating of “Hold” and a consensus target price of $20.71.

Envista Company Profile

Envista Holdings Corporation, together with its subsidiaries, develops, manufactures, markets, and sells dental products in the United States, China, and internationally. The company operates in two segments, Specialty Products & Technologies, and Equipment & Consumables. The Specialty Products & Technologies segment offers dental implant systems, guided surgery systems, biomaterials, and prefabricated and custom-built prosthetics to oral surgeons, prosthodontists and periodontists, and general dentist; and brackets and wires, tubes and bands, archwires, clear aligners, digital orthodontic treatments, retainers, and other orthodontic laboratory products.